"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_fax","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","relation","age at diagnosis:ch1","ebv status:ch1","gender:ch1","molecular diagnosis:ch1","pathology diagnosis:ch1","specimen:ch1","tumor biopsy origin:ch1"
"GSM429903","1373 (HIV+)","GSM429903","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_LN","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: LN","age at diagnosis: 37","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: BL","ebv status: negative","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429903/suppl/GSM429903.CEL.gz","54675","Reanalyzed by: GSE119087","37","negative","Male","BL","DLBCL","frozen ARL tumor biopsy","LN"
"GSM429904","1374 (HIV+)","GSM429904","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Lung","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Lung","age at diagnosis: 33","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: GCB DLBCL","ebv status: negative","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429904/suppl/GSM429904.CEL.gz","54675","Reanalyzed by: GSE119087","33","negative","Male","GCB DLBCL","DLBCL","frozen ARL tumor biopsy","Lung"
"GSM429905","1375 (HIV+)","GSM429905","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Colon","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Colon","age at diagnosis: 46","gender: Male","pathology diagnosis: DLBCL (PC)","molecular diagnosis: DLBCL_NC","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429905/suppl/GSM429905.CEL.gz","54675","Reanalyzed by: GSE119087","46","positive","Male","DLBCL_NC","DLBCL (PC)","frozen ARL tumor biopsy","Colon"
"GSM429906","1376 (HIV+)","GSM429906","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Sm Bowel","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Sm Bowel","gender: Male","pathology diagnosis: High Grade, UC","molecular diagnosis: DLBCL_NC","ebv status: negative","","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429906/suppl/GSM429906.CEL.gz","54675","Reanalyzed by: GSE119087",NA,"negative","Male","DLBCL_NC","High Grade, UC","frozen ARL tumor biopsy","Sm Bowel"
"GSM429907","1377 (HIV+)","GSM429907","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_LN","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: LN","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: BL","ebv status: negative","","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429907/suppl/GSM429907.CEL.gz","54675","Reanalyzed by: GSE119087",NA,"negative","Male","BL","DLBCL","frozen ARL tumor biopsy","LN"
"GSM429908","1378 (HIV+)","GSM429908","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Jejunum","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Jejunum","age at diagnosis: 33","gender: Male","pathology diagnosis: DLBCL (PC)","molecular diagnosis: ABC DLBCL","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429908/suppl/GSM429908.CEL.gz","54675","Reanalyzed by: GSE119087","33","positive","Male","ABC DLBCL","DLBCL (PC)","frozen ARL tumor biopsy","Jejunum"
"GSM429909","1379 (HIV+)","GSM429909","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Hilar/Lung","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Hilar/Lung","age at diagnosis: 57","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: DLBCL_NC","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429909/suppl/GSM429909.CEL.gz","54675","Reanalyzed by: GSE119087","57","positive","Male","DLBCL_NC","DLBCL","frozen ARL tumor biopsy","Hilar/Lung"
"GSM429910","1380 (HIV+)","GSM429910","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_LN","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: LN","age at diagnosis: 32","gender: Male","pathology diagnosis: High Grade, UC","molecular diagnosis: BL","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429910/suppl/GSM429910.CEL.gz","54675","Reanalyzed by: GSE119087","32","positive","Male","BL","High Grade, UC","frozen ARL tumor biopsy","LN"
"GSM429911","1383 (HIV+)","GSM429911","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Colon","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Colon","age at diagnosis: 35","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: GCB DLBCL","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429911/suppl/GSM429911.CEL.gz","54675","Reanalyzed by: GSE119087","35","positive","Male","GCB DLBCL","DLBCL","frozen ARL tumor biopsy","Colon"
"GSM429912","1387 (HIV+)","GSM429912","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Hilar","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Hilar","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: DLBCL_NC","ebv status: positive","","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429912/suppl/GSM429912.CEL.gz","54675","Reanalyzed by: GSE119087",NA,"positive","Male","DLBCL_NC","DLBCL","frozen ARL tumor biopsy","Hilar"
"GSM429913","1388 (HIV+)","GSM429913","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Pleural Fluid","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Pleural Fluid","age at diagnosis: 31","gender: Male","pathology diagnosis: High Grade, UC","molecular diagnosis: ABC DLBCL","ebv status: negative","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429913/suppl/GSM429913.CEL.gz","54675","Reanalyzed by: GSE119087","31","negative","Male","ABC DLBCL","High Grade, UC","frozen ARL tumor biopsy","Pleural Fluid"
"GSM429914","1390 (HIV+)","GSM429914","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_LN","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: LN","age at diagnosis: 24","gender: Male","pathology diagnosis: DLBCL (PC)","molecular diagnosis: ABC DLBCL","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429914/suppl/GSM429914.CEL.gz","54675","Reanalyzed by: GSE119087","24","positive","Male","ABC DLBCL","DLBCL (PC)","frozen ARL tumor biopsy","LN"
"GSM429915","1391 (HIV+)","GSM429915","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Mediastinal/Atrial","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Mediastinal/Atrial","age at diagnosis: 38","gender: Male","pathology diagnosis: DLBCL","molecular diagnosis: BL","ebv status: negative","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429915/suppl/GSM429915.CEL.gz","54675","Reanalyzed by: GSE119087","38","negative","Male","BL","DLBCL","frozen ARL tumor biopsy","Mediastinal/Atrial"
"GSM429916","1392 (HIV+)","GSM429916","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Neck","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Neck","age at diagnosis: 34","gender: Male","pathology diagnosis: High Grade, UC","molecular diagnosis: GCB DLBCL","ebv status: negative","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429916/suppl/GSM429916.CEL.gz","54675","Reanalyzed by: GSE119087","34","negative","Male","GCB DLBCL","High Grade, UC","frozen ARL tumor biopsy","Neck"
"GSM429917","1397 (HIV+)","GSM429917","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_LN","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: LN","age at diagnosis: 43","gender: Male","pathology diagnosis: DLBCL (PC)","molecular diagnosis: ABC DLBCL","ebv status: positive","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429917/suppl/GSM429917.CEL.gz","54675","Reanalyzed by: GSE119087","43","positive","Male","ABC DLBCL","DLBCL (PC)","frozen ARL tumor biopsy","LN"
"GSM429918","S02 (HIV+)","GSM429918","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_LN","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: LN","gender: Male","pathology diagnosis: DLBCL (PC)","molecular diagnosis: ABC DLBCL","ebv status: positive","","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429918/suppl/GSM429918.CEL.gz","54675","Reanalyzed by: GSE119087",NA,"positive","Male","ABC DLBCL","DLBCL (PC)","frozen ARL tumor biopsy","LN"
"GSM429919","S03 (HIV+)","GSM429919","Public on Mar 01 2010","Jul 20 2009","Aug 28 2018","RNA","1","Frozen Tumor Biopsy_Spinal/Epidural","Homo sapiens","specimen: frozen ARL tumor biopsy","tumor biopsy origin: Spinal/Epidural","gender: Male","pathology diagnosis: DLBCL (PC)","molecular diagnosis: ABC DLBCL","ebv status: positive","","total RNA","Total RNA was extracted using All Prep RNA/DNA kit (Qiagen, Valencia, CA) according to the manufacturers' protocols.","biotin","Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 2 microg total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","9606","Following fragmentation, 11 micrograms of cRNA were hybridized for 16 hours at 45C on U133 plus 2.0 arrays from Affymetrix. Arrays were washed and stained in the Affymetrix Fluidics Station 400.","Scanning was performed by the Affymetrix 3000 Scanner.","Gene expression data from frozen ARL tumor specimen","The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 100.","GPL570","Karen,,Deffenbacher","kdeffenb@unmc.edu","402-559-7753","402-559-4990","Chan","Pathology and Microbiology","University of Nebraska Medical Center","987660 Nebraska Medical Center","Omaha","NE","68198-7660","USA","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM429nnn/GSM429919/suppl/GSM429919.CEL.gz","54675","Reanalyzed by: GSE119087",NA,"positive","Male","ABC DLBCL","DLBCL (PC)","frozen ARL tumor biopsy","Spinal/Epidural"
